Hans Strander

5.1k total citations
117 papers, 3.6k citations indexed

About

Hans Strander is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hans Strander has authored 117 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 34 papers in Immunology and 30 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hans Strander's work include Cytokine Signaling Pathways and Interactions (23 papers), Sarcoma Diagnosis and Treatment (20 papers) and interferon and immune responses (15 papers). Hans Strander is often cited by papers focused on Cytokine Signaling Pathways and Interactions (23 papers), Sarcoma Diagnosis and Treatment (20 papers) and interferon and immune responses (15 papers). Hans Strander collaborates with scholars based in Sweden, Finland and Norway. Hans Strander's co-authors include Kari Cantell, Stefan Einhorn, Henric Blomgren, Eva Cavallin‐Ståhl, Alexandra Adams, K Cantell, Ingela Turesson, Gun Carlström, S. Haglund and P.‐G. Lundquist and has published in prestigious journals such as The Lancet, The Journal of Immunology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Hans Strander

114 papers receiving 3.1k citations

Peers

Countries citing papers authored by Hans Strander

Since Specialization

Citations

This map shows the geographic impact of Hans Strander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Strander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Strander more than expected).

Fields of papers citing papers by Hans Strander

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Strander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Strander. The network helps show where Hans Strander may publish in the future.

Co-authorship network of co-authors of Hans Strander

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Strander. A scholar is included among the top collaborators of Hans Strander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Strander. Hans Strander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A retrospective study of SBRT of metastases in patients with primary sarcoma 2012 ·Medical Oncology ·(unknown), Kristin Karlsson, Ingmar Lax, (unknown), Jonas Bergh, Hans Strander, Henric Blomgren, Signe Friesland	34
2	Interferon-α as the only adjuvant treatment in high-grade osteosarcoma: Long term results of the Karolinska Hospital series 2005 ·Acta Oncologica ·Christoph R. Müller, Sigbjørn Smeland, Henrik C. F. Bauer, Gunnar Sæter, Hans Strander	64
3	A Systematic Overview of Radiation Therapy Effects in Soft Tissue Sarcomas 2003 ·Acta Oncologica ·Hans Strander, Ingela Turesson, Eva Cavallin‐Ståhl	169
4	A Systematic Overview of Radiation Therapy Effects in Head and Neck Cancer 2003 ·Acta Oncologica ·Björn Zackrisson, Claes Mercke, Hans Strander, Johan Wennerberg, Eva Cavallin‐Ståhl	93
5	Low Levels of Endostatin in the Urine from Patients with Malignant Disease 2002 ·Tumor Biology ·(unknown), Hans Strander, Eva Munck‐Wikland, Margareta Sten-Linder	5
6	A Swedish Study of Chemoradiation in Squamous Cell Carcinoma of the Esophagus 2001 ·Acta Oncologica ·Dag Stockeld, Jan Tennvall, Gunnar Wagenius, Maria Albertsson, Lars Bäckman, Ola Brodin, Magdalena Cwikiel, L Granström, G Gustafsson, Sven Gustavsson, Göran Hambraeus, Rolf Lewensohn, Svante Sjöstedt, Hans Strander, Bengt Åberg, Jan Fagerberg	18
7	Distribution of stromelysin-3 mRNA transcripts and microvessels in human breast carcinomas 1997 ·Breast Cancer Research and Treatment ·(unknown), Georg Engel, Gert Auer, Hans Strander, Stig Linder	9
8	Interferons and the tumor cell 1996 ·Biotherapy ·Hans Strander, Stefan Einhorn	25
9	Long-Term Adjuvant Interferon Treatment of Human Osteosarcoma: A pilot study 1995 ·Acta Oncologica ·Hans Strander, Henrik C. F. Bauer, Otte Brosjö, (unknown), Andris Kreicbergs, Ulf Nilsonne, Claes Silfverswärd, (unknown), Veli Söderlund	39
10	Recombinant Leukocyte Interferon Alpha-2A and Medroxyprogesterone in Advanced Renal Cell Carcinoma: A Randomized Trial 1990 ·Acta Oncologica ·Gunnar Steineck, Hans Strander, (unknown), (unknown), L. Wallin, (unknown), Annie Arvidsson, Veli Söderlund, Ingemar Näslund, P. L. Esposti, Staffan E. Norell	56
11	Radiation Therapy in Early Glottic Cancer: Analysis of 177 Consecutive Cases 1989 ·Acta Oto-Laryngologica ·(unknown), Ulrik Ringborg, Claes Silfverswärd, (unknown), S. Haglund, H. Schiratzki, Hans Strander	22
12	Clinical evaluation of treatment with interferon 1989 ·Medical Oncology and Tumor Pharmacotherapy ·Hans Strander	2
13	Dacarbazine versus dacarbazine-vindesine in disseminated malignant melanoma: A randomized phase II study 1989 ·Medical Oncology and Tumor Pharmacotherapy ·Ulrik Ringborg, C.-M. Rudenstam, Johan Hansson, L Hafström, (unknown), Hans Strander	27
14	Comparison of Growth Inhibiting Effect of Natural and Recombinant Interferon-α on Human Osteosarcomas in Nude Mice 1987 ·Journal of Interferon Research ·Henrik C. F. Bauer, Otte Brosjö, Hans Strander	9
15	Does Successful Interferon Treatment of Tumor Patients Require Life-Long Treatment? 1987 ·Journal of Interferon Research ·Hans Strander, J. Boëthius, K Erhardt, S. Haglund, Tomas Hindmarsh, Bo Johansson, Ulf Nilsonne, Alfred Szamosi	17
16	Effect of Interferon on Heterotopic New Bone Formation in Mice 1984 ·Journal of Interferon Research ·Olle Nilsson, (unknown), Lars‐Åke Broström, Hans Strander, Ulf Nilsonne	4
17	The effect of systemic human interferon-alpha administration to patients with glioblastoma multiforme 1983 ·Acta Neurochirurgica ·(unknown), Henric Blomgren, V. Peter Collins, T. Greitz, Hans Strander	37
18	Interferon therapy in neoplastic diseases 1982 ·Philosophical transactions of the Royal Society of London. Series B, Biological sciences ·Hans Strander, Stefan Einhorn	8
19	Interferon Therapy in Juvenile Laryngeal Papillomatosis 1981 ·Archives of Otolaryngology - Head and Neck Surgery ·S. Haglund, P.‐G. Lundquist, Kari Cantell, Hans Strander	137
20	Virus infections and recurrence of osteosarcoma in patients receiving human leukocyte interferon 1980 ·International Journal of Cancer ·(unknown), Gun Carlström, Kari Cantell, Hans Strander	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact